Lenz therapeutics articles
-
Cullinan Therapeutics executive sells over $1.7m in stock
Jennifer Michaelson, the Chief Scientific Officer of Cullinan Therapeutics, Inc. (NASDAQ:CGEM), has sold a significant portion of her...
-
New therapeutic procedures in Cuba to treat movement disorders
Havana, May 5 (Prensa Latina) Non-invasive brain stimulation in its two variants (repetitive transcranial magnetic stimulation and transcranial direct current stimulation) are the new therapeutic procedures used by Cuban experts to treat movement disorders. The post New therapeutic procedures in Cuba to treat movement disorders first appeared on Prensa Latina.
-
TransCode Therapeutics Open Letter to Shareholders | National | wdrb.com
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ: RNAZ) today issued the following open letter to shareholders of the Company: